help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 71, No. 4 944-951
doi:10.1210/jcem-71-4-944
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FERRARI, P.
Right arrow Articles by SHAW, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FERRARI, P.
Right arrow Articles by SHAW, S.

Dysregulation of Atrial Natriuretic Factor in Hypertension-Prone Man*

PAOLO FERRARI, PETER WEIDMANN, CLAUDIA FERRIER, ROLAND DIETLER, RALPH HOLLMANN, REIN JAN PISO, JOSEPH WEY and SIDNEY SHAW

Medizinische Poliklinik, University of Berne Berne, Switzerland

Address all correspondence and requests for reprints to: Peter Weidmann, M.D., Medizinische Universitatspoliklinik, Freiburgstrasse 3, 3010 Bern/Switzerland.

To evaluate the hypothesis of an atrial natriuretic factor (ANF) deficiency in hypertension-prone humans, we investigated plasma ANF and other variables in 116 white offspring of normotensive parents (ONorm) or essential hypertensive parents (OHyp). Ten ONorm and 10 OHyp, all men matched for age and body habitus, were studied after 4 days of low (70 mmol/day) and high (350 mmol/day) dietary sodium intake. After mild sodium restriction, plasma ANF did not differ between ONorm and OHyp (9.7 ± 0.7 vs. 9.0 ± 1.3 fmol/L). On high sodium intake, plasma ANF increased in ONorm, but not in OHyp (to 18.3 ± 1.7 vs. 11.7 ± 1.7 fmol/L; P < 0.001). On the other hand, acute responses of plasma immunoreactive ANF (irANF) to saline loading or a norepinephrine-induced rise in blood pressure did not differ significantly between 8 ONorm and 8 OHyp. Fifty-one additional ONorm and 45 OHyp were evaluated during liberal sodium intake. Groups were further subdivided according to whether 24-h urinary sodium excretion was 91 mmol/m2 or less (modest salt intake) or more than 91 mmol/ m2 (high salt intake). Twenty-four-hour urinary sodium was similar in the 26 ONorm and 21 OHyp on a modest salt intake (121 ± 6 vs. 116 ± 9 mmol) and in the 25 ONorm and the 24 OHyp on a high salt intake (226 ± 10 vs. 221 ± 9 mmol). However, compared with ONorm, plasma irANF in OHyp was slightly lower on modest sodium intake (7.7 ± 0.7 vs. 5.3 ± 0.7 fmol/L; P < 0.05) and markedly reduced on high sodium intake (15.0 ± 1.3 vs. 8.0 ± 1.3 fmol/L; P < 0.001). Moreover, the slope of the relationship between plasma irANF and 24-h urinary sodium was flatter in OHyp than in ONorm (z test = 2.4).

We postulate a new endocrine syndrome characterized by a relative plasma ANF deficiency during high sodium intake in some hypertension-prone humans. This functional defect becomes apparent during chronic, rather than acute, stimulation of ANF release. It occurs as a familial disturbance and may potentially predispose to the development of hypertension,

* This work was supported in part by the Swiss National Science Foundation.

Received March 23, 1990.




This article has been cited by other articles:


Home page
PediatricsHome page
G. J. Legris, D. Dearborn, R. C. Stern, C. L. Geiss, U. Hopfer, J. G. Douglas, and C. F. Doershuk
Sodium Space and Intravascular Volume: Dietary Sodium Effects in Cystic Fibrosis and Healthy Adolescent Subjects
Pediatrics, January 1, 1998; 101(1): 48 - 56.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. M. Oliver, J. E. Fox, R. Kim, H. A. Rockman, H.-S. Kim, R. L. Reddick, K. N. Pandey, S. L. Milgram, O. Smithies, and N. Maeda
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
PNAS, December 23, 1997; 94(26): 14730 - 14735.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. M. Campese, M. Tawadrous, R. Bigazzi, S. Bianchi, A. S. Mann, S. Oparil, and L. Raij
Salt Intake and Plasma Atrial Natriuretic Peptide and Nitric Oxide in Hypertension
Hypertension, September 1, 1996; 28(3): 335 - 340.
[Abstract] [Full Text]


Home page
ScienceHome page
S. John, J. Krege, P. Oliver, Hagaman JR, J. Hodgin, S. Pang, T. Flynn, and O Smithies
Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension
Science, February 3, 1995; 267(5198): 679 - 681.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society